Forbes acquired by Luminar Technologies' Austin Russell https://ift.tt/YtMEgGp The deal values the company at $800 million, but key financing details were not disclosed.
CRISPR genome-editing technology helps scientists to explore many cancer-linked mutations https://ift.tt/Ro6XN1p Genomic studies of cancer patients have revealed thousands of mutations linked to tumor development.
0 ComentĂĄrios